REG - SkinBioTherapeutics OptiBiotix Health - Holding(s) in Company

SkinbiotherapeuticsAnnouncement

12/12/2024 14:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241212:nRSL9122Pa&default-theme=true

RNS Number : 9122P  SkinBioTherapeutics PLC  12 December 2024

TR-1: Standard form for notification of major holdings

 

 

 NOTIFICATION OF MAJOR HOLDINGS(to be sent to the relevant issuer and to the
 FCA in Microsoft Word format if possible)

 1a. Identity of the issuer or the underlying issuer of existing shares to
 which voting rights are attached:

                                                                                                                                                               SkinBioTherapeutics plc

                                                                                                                                                               Company No: 09632164 (England)

 1b. Please indicate if the issuer is a non-UK issuer(please mark with an "X"
 if appropriate)
 Non-UK issuer
 2. Reason for the notification(please mark the appropriate box or boxes with
 an "X")
 An acquisition or disposal of voting rights                                                                                                                                                                                                                X
 An acquisition or disposal of financial instruments
 An event changing the breakdown of voting rights
 Other (please specify):
 3. Details of person subject to the notification obligation
 Name                                                                                                                                                          Optibiotix Health PLC
 City and country of registered office (if applicable)                                                                                                         York (UK)
 4. Full name of shareholder(s)(if different from 3.)
 Name
 City and country of registered office (if applicable)
 5. Date on which the threshold was crossed or reached:                                                                                                        10 December 2024
 6. Date on which issuer notified (DD/MM/YYYY):                                                                                                                12 December 2024
 7. Total positions of person(s) subject to the notification obligation
                                                                                                                                    % of voting rights through financial instruments

                                                                            % of voting rights attached to shares (total of 8. A)   (total of 8.B 1 + 8.B 2)                              Total of both in % (8.A + 8.B)   Total number of voting rights held in issuer (8.A + 8.B) vii
 Resulting situation on the date on which threshold was crossed or reached

                                                                            9.58%                                                                                                         9.58%

                                                                                                                                                                                                                           21,884,389

 Position of previous notification (if applicable)

                                                    10.92%     10.92%   24,940,639

 

 

 

 8. Notified details of the resulting situation on the date on which the
 threshold was crossed or reached
 A: Voting rights attached to shares
 Class/type of shares                           Number of voting rights                                                                                      % of voting rights

 ISIN code (if possible)
                                                Direct                                Indirect                                                               Direct                             Indirect

                                                (DTR5.1)                              (DTR5.2.1)                                                             (DTR5.1)                           (DTR5.2.1)
 Ordinary                                       21,884,389                                                                                                   9.58%

 SUBTOTAL 8. A                                  21,884,389                                                                                                   9.58%

 B 1: Financial Instruments according to DTR5.3.1R (1) (a)
                                                                                                                          Number of voting rights that may be acquired if the instrument is

                                                     exercised/converted.

 Type of financial instrument                   Expiration date x   Exercise/ Conversion Period xi

                                                                                                                                                                                                % of voting rights

                                                                    SUBTOTAL 8. B 1

 B 2: Financial Instruments with similar economic effect according to DTR5.3.1R
 (1) (b)
 Type of financial instrument  Expiration date x                    Exercise/ Conversion Period xi      Physical or cash Settlement xii                      Number of voting rights

                                                                                                                                                                                                % of voting rights

 SUBTOTAL 8.B.2

 

 

 

 

 

 9. Information in relation to the person subject to the notification
 obligation (please mark the applicable box with an "X")
 Person subject to the notification obligation is not controlled by any natural                                                                                                                                             X
 person or legal entity and does not control any other undertaking(s) holding
 directly or indirectly an interest in the (underlying) issuer xiii
 Full chain of controlled undertakings through which the voting rights and/or
 the

 financial instruments are effectively held starting with the ultimate
 controlling natural person or legal entity (please add additional rows as
 necessary) xiv
                                                                                                          % of voting rights through financial instruments if it equals or is higher

                                                                            than the notifiable threshold

                             % of voting rights if it equals or is higher than the notifiable threshold                                                                               Total of both if it equals or is higher than the notifiable threshold

 Name

 10. In case of proxy voting, please identify:
 Name of the proxy holder
 The number and % of voting rights held
 The date until which the voting rights will be held

 11. Additional information

 Place of completion  London
 Date of completion   11 December 2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  HOLTTBITMTIBBTI